Biopharmaceutical Analysis & Statistics, July 2013 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: Protein, Biomedical, Antibody, more »

571-600 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Multispan Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Multispan Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Multispan Inc. (Multispan) is a biotechnology company. The company conducts GPCR drug discovery research by providing GPCR cell biology platform solutions. Its products include GPCR cell lines ...

  • Industries : Biopharmaceutical
  • Countries : United States
MedImmune Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MedImmune Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary MedImmune Limited (MedImmune) is a biotechnology company, based in the UK. The company conducts research and develops human monoclonal antibodies. Its products include synagis, flumist and amifostine. ...

  • Industries : Biopharmaceutical
Vybion, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vybion, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Vybion, Inc. (Vybion) is a pharmaceutical company. The company manufactures human monoclonal antibody drugs. Its product under clinical development includes INT41, is used in the treatment of Huntington's ...

  • Industries : Biopharmaceutical
  • Countries : United States
R&D Biopharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

R&D Biopharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary R&D Biopharmaceuticals GmbH (R&D-Biopharmaceuticals) is a biotechnology company. The company centers on pre-clinical and clinical development of unique small molecules deriving from natural products ...

  • Industries : Biopharmaceutical
Saamya Biotech (India) Ltd. (532905) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Saamya Biotech (India) Ltd. (532905) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Saamya Biotech (India) Ltd. is a Biotechnology company. The company is engaged in manufacturing biopharmaceuticals and recombinant protein products. It is headquartered in Andhra Pradesh, India. ...

  • Industries : Biopharmaceutical
  • Countries : India
Neugenesis Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Neugenesis Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Neugenesis Corporation (Neugenesis) is a privately held biotechnology company that is engaged in the development of technology platforms for the discovery and production of biotherapeutics. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
China Biopharmaceuticals Market Report

China Biopharmaceuticals Market Report

  • $ 680
  • Industry report
  • July 2013
  • by Beijing Zeefer Consulting Ltd

This report presents a clear picture about the overall development of biopharmaceuticals market in China and the trend in recent years based on detailed data analysis. This report includes the analysis ...

  • Industries : Biopharmaceutical
  • Countries : China
Protein Target & Pipeline Database: 1-Year Subscription

Protein Target & Pipeline Database: 1-Year Subscription

  • $ 1 584
  • Industry report
  • July 2013
  • by La Merie Publishing

Protein Target & Pipeline Database: 1-Year Subscription Product description Subscription to La Merie Publishing’s proprietary Protein Database provides online access to information about more than ...

  • Industries : Biopharmaceutical
Immunotope, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunotope, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Immunotope, Inc. (Immunotope) is a biotechnology company. It develops immunotherapy products for the prevention and treatment of cancer and chronic viral infections. Immunotope's product IMT-1012 ...

  • Industries : Biopharmaceutical
  • Countries : United States
Huifeng BioPharmaceutical Technology Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Huifeng BioPharmaceutical Technology Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Huifeng BioPharmaceutical Technology Inc. (Huifeng) is a biopharmaceutical company. The company develops, produces and markets plant extracts, pharmaceuticals and pharmaceutical raw materials in ...

  • Industries : Biopharmaceutical
  • Countries : China
Fujifilm Diosynth Biotechnologies U.S.A., Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fujifilm Diosynth Biotechnologies U.S.A., Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Fujifilm Diosynth Biotechnologies (Diosynth) is a biologics contract manufacturer. The company provides cGMP manufacturing services. Its manufacturing capabilities include monoclonal antibodies, ...

  • Industries : Biopharmaceutical
  • Countries : United States
XTL Biopharmaceuticals Ltd. (XTLBY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

XTL Biopharmaceuticals Ltd. (XTLBY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary XTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. The company acquires, develops and commercializes therapeutics for the treatment of multiple myeloma and hepatitis C. Its product ...

  • Industries : Biopharmaceutical
3P Biopharmaceuticals S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

3P Biopharmaceuticals S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary 3P Biopharmaceuticals S.L. (3P Biopharmaceuticals) is a contract manufacturing organization. It develops biological and cell therapy products in compliance with international regulatory requirements. ...

  • Industries : Biopharmaceutical
Calypte Biomedical Corporation (CBMC) - Medical Equipment - Deals and Alliances Profile

Calypte Biomedical Corporation (CBMC) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Calypte Biomedical Corporation (Calypte) is a diagnostic company. It carries out the development, manufacture and marketing of in-vitro testing algorithms for improved diagnosis of HIV infection ...

  • Industries : Biopharmaceutical
  • Countries : United States
Competitor Analysis ErbB / Her Receptor Antagonists

Competitor Analysis ErbB / Her Receptor Antagonists

  • $ 858
  • Industry report
  • July 2013
  • by La Merie Publishing

Competitor Analysis ErbB / Her Receptor Antagonists Product description The present Competitive Intelligence Report about antagonists of the ErbB/Her receptor pathway provides a competitor evaluation ...

  • Industries : Biopharmaceutical
Biopharmaceuticals - A Global Market Overview

Biopharmaceuticals - A Global Market Overview

  • $ 4 500
  • Industry report
  • July 2013
  • by Industry Experts

`The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Sports Nutrition in Pakistan

Sports Nutrition in Pakistan

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Despite having a young population and increased awareness, Pakistan continues to experience an overall low health consciousness as consumers across most income groups are concerned with feeding their families ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Pakistan
Sports Nutrition Market Overview in Estonia

Sports Nutrition Market Overview in Estonia

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Sports nutrition in Estonia declined by nearly 5% as value sales accounted for EEK720,000 in 2010. As many people ended their memberships at various sports clubs, the sales of sports nutrition in Estonia ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Estonia
Sports Nutrition Market Analysis in Nigeria

Sports Nutrition Market Analysis in Nigeria

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

And with an improved economy in 2010 compared to the previous year, the category saw a growth rate of 11% in current value terms. This is slower than the review period average, due to the fact that the ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Nigeria
Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023

Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023

  • $ 2 846
  • Industry report
  • July 2013
  • by Visiongain

Report Details Biosimilar monoclonal antibodies - this new study shows you potential sales What does the future hold for biosimilar therapeutic antibodies? Visiongain's new report predicts revenues to ...

  • Industries : Biopharmaceutical
  • Countries : World
The Global Food and Beverage Processing Enzyme Market 2013 2018: Trends, Forecast, and Opportunity Analysis, July 2013

The Global Food and Beverage Processing Enzyme Market 2013 2018: Trends, Forecast, and Opportunity Analysis, July 2013

  • $ 3 900
  • Industry report
  • July 2013
  • by Lucintel

Background: The worldwide enzyme market for food and beverage industry is expected to reach $1.69 billion by 2018, with a moderate growth over the next five years. The use of enzyme is growing in food ...

  • Industries : Biopharmaceutical
  • Countries : World
Sports Nutrition in Georgia

Sports Nutrition in Georgia

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

The awareness of sports nutrition and the consuming culture of the category are rather low in Georgia. It was first introduced in Georgia only in 2011, with Trec Nutrition as the pioneer company. Before ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Georgia
Antibody Target, Technology & Pipeline Database: 1-year Subscription

Antibody Target, Technology & Pipeline Database: 1-year Subscription

  • $ 1 716
  • Industry report
  • July 2013
  • by La Merie Publishing

Antibody Target, Technology & Pipeline Database: 1-Year Subscription Product description Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about ...

  • Industries : Biopharmaceutical
Zenotech Laboratories Limited (Symbol:532039) SWOT Analysis, Strategy, Revenues and Profits

Zenotech Laboratories Limited (Symbol:532039) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Sports Nutrition Market Analysis in Italy

Sports Nutrition Market Analysis in Italy

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Anecdotal evidence, as well as fitness market sources, indicate that a rising number of people have a fitness club membership. This trend is further supported by vanity and health concerns among younge ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Italy
Physician Views: Biosimilar Remicade poised for approval in Europe - are rheumatologists and gastroenterologists ready?

Physician Views: Biosimilar Remicade poised for approval in Europe - are rheumatologists and gastroenterologists ready?

  • $ 645
  • Industry report
  • July 2013
  • by Firstword Pharma

Scope of the Report The recent recommendation to approve a biosimilar version of Merck & Co./Johnson & Johnson's Remicade in Europe has gone a long way to validate the regulatory pathway for biosimila ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Charting the Biosimilar and Biobetter Development Pipeline (2013)

Charting the Biosimilar and Biobetter Development Pipeline (2013)

  • $ 1 950
  • Industry report
  • July 2013
  • by Firstword Pharma

If you need to understand the important biosimilar and biobetter drug developments worldwide then this report is critical. The promise of biosimilars has been great but beyond the first wave of products ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Enzymes Markets in China

Enzymes Markets in China

  • $ 4 000
  • Industry report
  • July 2013
  • by Asia Market Information & Development Company

China's demand for enzymes has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment ...

  • Industries : Biopharmaceutical
  • Countries : China
STRATEC Biomedical Systems AG (Symbol:SBS) SWOT Analysis, Strategy, Revenues and Profits

STRATEC Biomedical Systems AG (Symbol:SBS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Bleeding And Clotting Disorders - Pipeline Review, H1 2013

Bleeding And Clotting Disorders - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Bleeding And Clotting Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Bleeding And Clotting Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...

  • Industries : Biopharmaceutical
  • Countries : China

28 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.